Lassa Fever 2016 Outbreak in Plateau State, Nigeria—The Changing Epidemiology and Clinical Presentation

Nathan Y. Shehu(Jos University Teaching Hospital), Simji Samuel Gomerep(Jos University Teaching Hospital), Samson E. Isa(Jos University Teaching Hospital), Kelly Iraoyah(Irrua Specialist Teaching Hospital), Johnson Mafuka(Jos University Teaching Hospital), Nandom Bitrus(Jos University Teaching Hospital), Matthias C. Dachom(Jos University Teaching Hospital), John E. Ogwuche(Jos University Teaching Hospital), Asukwo Onukak(Jos University Teaching Hospital), Kenneth I. Onyedibe(Jos University Teaching Hospital), Ephraim Ogbaini-Emovon(Irrua Specialist Teaching Hospital), Daniel Egah(Jos University Teaching Hospital), Elizabeth J. Mateer(The University of Texas Medical Branch at Galveston), Slobodan Paessler(The University of Texas Medical Branch at Galveston)
Frontiers in Public Health
August 29, 2018
Cited by 41Open Access
Full Text

Abstract

Lassa fever (LF) outbreaks in Nigeria mostly occur in rural areas and during the dry season, peaking between December through February. Fever is a cardinal presenting feature among the myriad manifestations of LF. Thirty four patients with clinical diagnosis of LF were analyzed. However, only 11 (32%) LASV infections were confirmed by RT-PCR. The 2016 LF outbreak showed a preferential urban occurrence and a high case fatality. Fever (≥38C ) was not detected in over a fourth of the patients at the time of examination. Bleeding diathesis was the most common presentation while abdominal pain and headache were present in more than half of the confirmed cases. Changes in the geographical distribution and clinical presentation may have implications for disease control efforts and the risk of transmission, both locally and internationally. In order to guide interventions, public health authorities should be aware that the epidemic patterns may be changing.


Related Papers

No related papers found

Powered by citation graph analysis